3,5-Dibromobenzoic Acid acts as a reagent for the design, synthesis and hypoglycemic activity of cyclopropane-bearing C-glucoside as SGLT2 inhibitors. Also used as a reagent for the preparation of substituted piperidines as renin inhibitors for treatment of cardiovascular events and renal insufficiency.